Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial

AIM: To evaluate the use of recombinant human fibroblast growth factor (rhFGF)‐2 in combination with deproteinized bovine bone mineral (DBBM) compared with rhFGF‐2 alone, in the treatment of intrabony periodontal defects. MATERIALS AND METHODS: Patients with periodontitis who had received initial pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Atsushi, Bizenjima, Takahiro, Takeuchi, Takahiro, Suzuki, Eiichi, Sato, Masahiro, Yoshikawa, Kouki, Kitamura, Yurie, Matsugami, Daisuke, Aoki, Hideto, Kita, Daichi, Imamura, Kentaro, Irokawa, Daisuke, Seshima, Fumi, Tomita, Sachiyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Periodontal Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899590/
https://www.ncbi.nlm.nih.gov/pubmed/30758076
http://dx.doi.org/10.1111/jcpe.13086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899590/
https://www.ncbi.nlm.nih.gov/pubmed/30758076
http://dx.doi.org/10.1111/jcpe.13086

Ejemplares similares